Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert.
Iron regulatory proteins, IRP1 and IRP2, bind to mRNAs harboring iron responsive elements and control their expression. IRPs may also perform additional functions. Thus, IRP1 exhibited apparent tumor suppressor properties in a tumor xenograft model. Here we examined the effects of IRP2 in a similar setting. Human H1299 lung cancer cells or clones engineered for tetracycline-inducible expression of wild type IRP2, or the deletion mutant IRP2(Delta73) (lacking a specific insert of 73 amino acids), were injected subcutaneously into nude mice. The induction of IRP2 profoundly stimulated the growth of tumor xenografts, and this response was blunted by addition of tetracycline in the drinking water of the animals, to turnoff the IRP2 transgene. Interestingly, IRP2(Delta73) failed to promote tumor growth above control levels. As expected, xenografts expressing the IRP2 transgene exhibited high levels of transferrin receptor 1 (TfR1); however, the expression of other known IRP targets was not affected. Moreover, these xenografts manifested increased c-MYC levels and ERK1/2 phosphorylation. A microarray analysis identified distinct gene expression patterns between control and tumors containing IRP2 or IRP1 transgenes. By contrast, gene expression profiles of control and IRP2(Delta73)-related tumors were more similar, consistently with their growth phenotype. Collectively, these data demonstrate an apparent pro-oncogenic activity of IRP2 that depends on its specific 73 amino acids insert, and provide further evidence for a link between IRPs and cancer biology.
Maffettone
Carmen
C
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, and Department of Medicine, McGill University, Montreal, Quebec, Canada.
Chen
Guohua
G
Drozdov
Ignat
I
Ouzounis
Christos
C
Pantopoulos
Kostas
K
D000818:Animals; D045744:Cell Line, Tumor; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D035942:Iron Regulatory Protein 2 / Q000235:genetics* / Q000502:physiology; D008175:Lung Neoplasms / Q000209:etiology*; D051379:Mice; D008819:Mice, Nude; D008822:Mice, Transgenic; D017384:Sequence Deletion; D014183:Transplantation, Heterologous
D035942:Iron Regulatory Protein 2
Mol Cell Biol. 2007 Apr;27(7):2423-30
17242182
PLoS Comput Biol. 2007 Oct;3(10):2032-42
17967053
J Biol Chem. 2003 Oct 10;278(41):40337-42
12888568
Nat Genet. 2001 Feb;27(2):209-14
11175792
Nucleic Acids Res. 2002 Apr 1;30(7):1575-84
11917018
Toxicol Appl Pharmacol. 2005 Jan 15;202(2):199-211
15629195
Mol Cell Biol. 2002 Jul;22(13):4638-51
12052872
Biochim Biophys Acta. 2006 Jul;1763(7):668-89
16872694
Biochem J. 2007 Dec 15;408(3):429-39
17760563
Nat Rev Cancer. 2008 Dec;8(12):976-90
19029958
J Biol Chem. 2006 Aug 11;281(32):22865-74
16760464
Cell Cycle. 2008 Mar 1;7(5):592-6
18256542
Cell Metab. 2009 May;9(5):461-73
19416716
J Biol Chem. 2007 Aug 24;282(34):24650-9
17604281
Annu Rev Nutr. 2008;28:197-213
18489257
Blood. 2005 Oct 1;106(7):2580-9
15956281
Mol Cell Biol. 2004 Feb;24(3):954-65
14729944
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):283-7
16480904
EMBO J. 2004 Jan 28;23(2):386-95
14726953
Science. 2009 Oct 30;326(5953):722-6
19762597
J Nutr. 1997 Feb;127(2):238-48
9039823
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12345-50
12209011
Science. 1999 Jan 29;283(5402):676-9
9924025
Carcinogenesis. 2007 Apr;28(4):785-91
17127713
BMC Mol Biol. 2008 Jan 28;9:15
18226225
Science. 2009 Oct 30;326(5953):718-21
19762596
J Trace Elem Med Biol. 2010 Jan;24(1):58-66
20122582
Nat Chem Biol. 2006 Aug;2(8):406-14
16850017
Methods Enzymol. 2002;348:324-37
11885287
Mol Cell. 2008 Dec 26;32(6):838-48
19111663
Cell Metab. 2008 Jan;7(1):79-85
18177727
Nat Struct Mol Biol. 2007 May;14(5):420-6
17417656
Blood. 2005 Aug 1;106(3):1084-91
15831703
Science. 2004 Dec 17;306(5704):2087-90
15604406